iShares Russell 2000 Growth ETF
iShares Trust · Series S000004343 · 1 share classes
data updated 2026-09-08
Fund profile
As filed in the prospectus · 2025 Q3
The iShares Russell 2000 Growth ETF (the Fund ) seeks to track the investment results of an index composed of small-capitalization U.S. equities that exhibit growth characteristics.
The fund tracks the Russell 2000 Growth Index, a subset of the Russell 2000 composed of small-cap U.S. equities with higher price-to-book ratios, sales growth, and forecasted growth, using representative sampling to hold a portfolio with similar investment characteristics to the index. Because the fund may not hold all index constituents, its returns may diverge from the index. The index applies a capping methodology that limits any single holding to 22.5% of index weight and restricts holdings above 4.5% to 45% in aggregate, and rebalances quarterly.
| Share class | Expense ratio |
|---|---|
| IWO | 0.24% |
Portfolio turnover 30.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.62% |
| Cash & short-term | 14.76% |
| Other | 0.01% |
| Derivatives | 0.00% |
These positions come to 114.39% of the fund's net assets. This counts only what the fund reported holding — the holdings disclosure covers assets, not liabilities such as borrowings — so it is not expected to reconcile to 100%.
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | BlackRock Funds III | 14.75% | — | $2.28B | — |
| MOG/A | Moog, Inc.MOG/A | 0.73% | $423.84 | $112.12M | 264.5K |
| BTSG | BrightSpring Health Services, Inc.BTSG | 0.68% | $69.74 | $105.08M | 1.5M |
| MXL | MaxLinear, Inc.MXL | 0.66% | $128.03 | $102.41M | 799.9K |
| AGX | Argan, Inc.AGX | 0.66% | $798.55 | $101.33M | 126.9K |
| — | JFrog Ltd. | 0.59% | $90.88 | $91.61M | 1.0M |
| KRYS | Krystal Biotech, Inc.KRYS | 0.58% | $371.67 | $89.68M | 241.3K |
| ESE | ESCO Technologies, Inc.ESE | 0.56% | $350.04 | $85.64M | 244.7K |
| FCFS | FirstCash Holdings, Inc.FCFS | 0.53% | $216.32 | $82.30M | 380.5K |
| QBTS | D-Wave Quantum, Inc.QBTS | 0.53% | $23.99 | $81.83M | 3.4M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 20.27% of net assets, top 25 27.43%, across 1.1K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free